1. Home
  2. LGND vs NWE Comparison

LGND vs NWE Comparison

Compare LGND & NWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • NWE
  • Stock Information
  • Founded
  • LGND 1987
  • NWE 1923
  • Country
  • LGND United States
  • NWE United States
  • Employees
  • LGND 68
  • NWE N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • NWE Power Generation
  • Sector
  • LGND Health Care
  • NWE Utilities
  • Exchange
  • LGND Nasdaq
  • NWE Nasdaq
  • Market Cap
  • LGND 3.2B
  • NWE 3.5B
  • IPO Year
  • LGND 1992
  • NWE N/A
  • Fundamental
  • Price
  • LGND $205.69
  • NWE $68.25
  • Analyst Decision
  • LGND Strong Buy
  • NWE Hold
  • Analyst Count
  • LGND 8
  • NWE 5
  • Target Price
  • LGND $144.71
  • NWE $59.80
  • AVG Volume (30 Days)
  • LGND 139.7K
  • NWE 564.9K
  • Earning Date
  • LGND 08-05-2025
  • NWE 10-29-2025
  • Dividend Yield
  • LGND N/A
  • NWE 3.87%
  • EPS Growth
  • LGND N/A
  • NWE N/A
  • EPS
  • LGND N/A
  • NWE 3.53
  • Revenue
  • LGND $181,488,000.00
  • NWE $1,569,761,000.00
  • Revenue This Year
  • LGND $18.41
  • NWE $6.08
  • Revenue Next Year
  • LGND $18.87
  • NWE $4.48
  • P/E Ratio
  • LGND N/A
  • NWE $19.35
  • Revenue Growth
  • LGND 53.40
  • NWE 4.90
  • 52 Week Low
  • LGND $81.74
  • NWE $50.43
  • 52 Week High
  • LGND $129.90
  • NWE $68.48
  • Technical
  • Relative Strength Index (RSI)
  • LGND 59.63
  • NWE 73.73
  • Support Level
  • LGND $198.82
  • NWE $65.40
  • Resistance Level
  • LGND $209.10
  • NWE $67.23
  • Average True Range (ATR)
  • LGND 7.14
  • NWE 1.51
  • MACD
  • LGND -0.67
  • NWE 0.12
  • Stochastic Oscillator
  • LGND 53.60
  • NWE 99.64

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About NWE NorthWestern Energy Group Inc.

NorthWestern Energy Group Inc provides electricity and natural gas services in the Upper Midwest and Northwest of the U.S. in the states of Montana, South Dakota, Nebraska, and Yellowstone National Park. The company's primary segments include Electric utility operations, which include the generation, purchase, transmission, and distribution of electricity, and Natural Gas utility operations, which include the production, purchase, transmission, storage, and distribution of natural gas. The company uses thermal, wind, hydro, or renewable energy in varying quantities, depending on the location of the facilities, to generate power. The company derives the majority of its revenue from the Electric utility operations segment.

Share on Social Networks: